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Abstract To investigate the frequency-dependent changes in
the amplitude of low-frequency fluctuations (ALFF) in pa-
tients with Wilson’s disease (WD). Resting-state function
magnetic resonance imaging (R-fMRI) were employed to
measure the amplitude of ALFF in 28 patients with WD and
27 matched normal controls. Slow-5 (0.01–0.027 Hz) and
slow-4 (0.027–0.073 Hz) frequency bands were analyzed.
Apart from the observation of atrophy in the cerebellum, basal
ganglia, occipital gyrus, frontal gyrus, precentral gyrus, and
paracentral lobule, we also found widespread differences in
ALFF of the two bands in the medial frontal gyrus, inferior
temporal gyrus, insula, basal ganglia, hippocampus/
parahippocampal gyrus, and thalamus bilaterally. Compared
to normal controls, WD patients had increased ALFF in the
posterior lobe of the cerebellum, inferior temporal gyrus, brain
stem, basal ganglia, and decreased ALFF in the anterior lobe
of the cerebellum and medial frontal gyrus. Specifically, we
observed that the ALFF abnormalities in the cerebellum and
middle frontal gyrus were greater in the slow-5 than in the
slow-4 band. Correlation analysis showed consistently posi-
tive correlations between urinary copper excretion (Cu),
serum ceruloplasmin (CP) and ALFFs in the cerebellum.
Our study suggests the accumulation of copper profoundly
impaired intrinsic brain activity and the impairments
seem to be frequency-dependent. These results provide
further insights into the understanding of the pathophysiology
of WD.
Keywords Wilson’s disease . Resting-state functional
magnetic resonance imaging . Amplitude of low-frequency
fluctuations
Background
Wilson’s disease (WD) or hepatolenticular degeneration, is
first defined by Alexander Kinnier Wilson in 1912 (Wilson
1912). The physical burden of the disease falls largely in the
liver and brain (Reilly et al. 1993). Accumulation of cooper in
the liver can lead to elevated serum aminotransferases, chronic
hepatitis, and cirrhosis (Ala et al. 2007). In the brain, most
copper is deposited in the basal ganglia, particularly in the
lenticular nucleus, which areas normally participate in action
selection, movement control, procedural and reward learning,
and emotion regulation (Yamada et al. 2004; Turner et al.
2003; Packard and Knowlton 2002; Radua et al. 2010).
About half the people withWilson’s disease will develop neu-
rological or psychiatric symptoms, such as mild cognitive de-
terioration in the early stage (de Bie et al. 2007), and dysar-
thria, abnormal gait, risus sardonicus, dystonia, rigidity, bra-
dykinesia in the late stages (Machado et al. 2006), indicating
potential brain changes in WD patients. Previous studies have
revealed generalized brain atrophy, lesions in the brainstem,
cerebellum, basal ganglia, subcortical white matter, midbrain,
and pons of WD patients with conventional magnetic reso-
nance imaging (MRI) (Page et al. 2004; Sinha et al. 2006;
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Magalhaes et al. 1994; Starosta-Rubinstein et al. 1987), diffu-
sion or focal hypoperfusion in superior frontal, prefrontal,
parietal, occipital cortices, in temporal gyri, caudatus and pu-
tamen with single photon emission computed tomography
(SPECT) studies (Piga et al. 2008), and decreased cerebellar,
striatal and cortical and thalamic regional cerebral metabolic
rate of glucose consumption (rCMRGlc) with positron
emission tomography (PET) (Kuwert et al. 1992;
Hawkins et al. 1987). In the current study, we collected
both structural and resting-state imaging data in WD
patients and normal controls, aiming to provide addi-
tional information other than structural changes about
how WD will affect brain.
In the last two decades, reliable and easy-to-perform
resting-state functional magnetic resonance imaging (R-
fMRI) has attracted more and more attention in the di-
agnosis of brain activities since Biswal and his col-
leagues (Biswal et al. 1995) first reported that sponta-
neous low-frequency oscillations (LFO; 0.01–0.08 Hz)
of blood oxygen level-dependent (BOLD) signal were physi-
ologically informative. Amplitude of low-frequency fluctua-
tions (ALFF), characterizing the local brain features of R-
fMRI data, is one of the most frequently used approaches that
quantify the regional neural synchronous activity by assessing
the amplitude of power spectrum of LFO (Zang et al. 2007).
The ALFF analysis has been used to detect brain abnor-
malities in a spectrum of diseases, such as the attention-
deficient hyperactivity disorder (Zang et al. 2007),
Alzheimer’s disease (He et al. 2007), and posttraumatic
stress disorder (Yin et al. 2011). While resting-state
PET/SPECT directly measures the metabolism of local
brain areas, the ALFF measures the deviation of the
BOLD signal and may provide extra information about
how disease affects brain.
In the present study, we utilized ALFF of R-fMRI to
examine WD-related abnormal changes in LFO amplitudes.
We computed ALFF at the slow-5 (0.01–0.027 Hz) and
slow-4 bands (0.027–0.073 Hz) to evaluate if the WD-
related deficits were frequency-specific. Stronger ALFF
at slow-5 tended to be present in the cortical structures,
and stronger slow-4 tended to be present in the subcor-
tical structures (Zou et al. 2010). Moreover, several diseases
have been shown to be band specific (Hoptman et al. 2010;
Wang et al. 2014). Since other frequency bands, e.g.
slow-6 (0–0.01 Hz), slow-3 (0.073–0.198 Hz), and
slow-2 (0.198–0.25 Hz), may mingle with very low fre-
quency drift, the white matter (WM) signals, and high-
frequency physiological noises, they were not analyzed
(Biswal et al. 1995; Zou et al. 2010). We also investigated
the associations between ALFF and biochemical measures,
e.g. 24-h urinary copper excretion (Cu) and serum ceruloplas-
min (CP), aiming to confirm the relationship between ALFF
measures and clinical diagnosis.
Method
Subjects
Twenty-eight neurological WD patients (18 males), with
21.43 ± 3.56 years (mean ± s.d.), were recruited from the
Institute of Neurology at Anhui University of Chinese
Medicine, Hefei, China. The mean duration of illness was
6.67 (± 1.46, s.d.) years when they participated the study.
Neurological WD patients were hospitalized and were intrave-
nously administered sodium dimercaptopropanesulfonate
(DMPS) at a dose of 15–20 mg/kg throughout the course of
the treatment to promote the urinary excretion of copper. Each
treatment course consisted of DMPS therapy for 6 consecutive
days, followed by a withdrawal period of 2 days to promote
tolerance. Every patient received repeated DMPS therapy for 8
to 10 courses every year. All patients demonstrated neurologi-
cal improvements and decreased urinary copper excretion after
6 courses but experienced worsening of symptoms after
6 months to 1 year post DMPS therapy. All neurological WD
patients who participated in this study didn’t receive any treat-
ments during the past 6 months before this study. They began
the treatment after the procedure of diagnosis and scanning.
The diagnosis was made based on clinical symptoms (e.g.,
presentation of extrapyramidal symptoms and signs, with dys-
arthria and tremor, and remarkable impairment of liver func-
tion), the presence of the Kayser-Fleischer Ring (the KF ring),
and abnormal copper metabolism (decreased levels of serum
ceruloplasmin: CP < 20 mg/dL; increased 24-h urinary excre-
tion of copper: 24-h urinary Cu > 1.6 μmol/day) (European
Association For The Study Of The Liver 2012). The average
24-h urinary Cu was 2.42 ± 1.48 μmol/day (mean ± s.d.) and
the average CP was 6.15 ± 2.51 mg/dL (mean ± s.d.) based on
the group of neurological WD patients. Twenty-seven normal
controls (NC; 15 males), aged 23.41 ± 2.65 years (mean ± s.d.),
were recruited from the local community. Subjects (patients
and normal controls) with history of head injury, neurological
disorders, or concomitant medical disorders were excluded. All
subjects, with written informed consents, were scanned within
24 h of initial contact. This study was approved by the Medical
Research Ethics Committee of Anhui Medical University. The
characteristics of all subjects were summarized in Table 1.
MRI data acquisition
All subjects were scanned on a GE HDxt (General Electric
Medical Systems, Milwaukee, WI, USA) 3.0 T magnetic reso-
nance scanner at the first-affiliated hospital of Anhui Medical
University. Resting-state fMRI was obtained using an 480-s
EPI (echo planar imaging) pulse sequence: TR (repetition
time) = 2000 ms, TE (echo time) = 30ms, flip angle =90°, field
of view =240 × 240 mm2, voxel size =3.75 × 3.75 × 3.75 mm3,
matrix =64 × 64, number of slices =39, slice thickness = 3mm,
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gap =0.8 mm. For structural imaging, a 3-dimensional
spoiled gradient-recalled acquisition (3D–SPGR) tech-
nique was used: TR = 7.012 ms, TE = 2.876 ms, TI = 900
ms, flip angle =8°, field of view =256× 256 mm2, voxel
size =0.94 × 0.94 × 1.2 mm3, matrix =256 × 256, slice thick-
ness = 1 mm without gap, 166 slices.
Data preprocessing
The preprocessing was carried out using Data Processing
Assistant for Resting-State fMRI (DPARSF, http://www.
restfmri.net/) (Chao-Gan and Yu-Feng 2010), which is based
on Statistical Parametric Mapping (SPM8, http://www.fil.ion.
ucl.ac.uk/spm/) and Resting-State fMRI Data Analysis Toolkit
(REST, http://www.restfmri.net/) (Song et al. 2011). First ten
volumes were discarded to allow MRI signal to reach a steady
state and the subjects to get used to the scanner environment. The
remaining fMRI images were slice-acquisition and head-motion
corrected with a least-square approach and a six-parameter spa-
tial transformation. Three WD patients and one normal control
were excluded according to the criteria that head motion was
restricted to less than 2 mm of displacement or 2 degrees of
rotation in any directions. Six motion parameters, the cerebro-
spinal fluid (CSF), and the white matter signals were used as
nuisance covariates to reduce the effects of headmotion and non-
neuronal BOLD fluctuations (Biswal et al. 1995; Zou et al. 2010
). All functional data were normalized to the standard SPM8
Montreal Neurological Institute (MNI) template by applying
the transformation parameters obtained from the structural im-
ages to those corrected images, and then resampled to 3-mm3
voxels. The resultant normalized functional images were spatial-
ly smoothed with a Gaussian kernel of 4-mm full width at half
maximum (FWHM) and removed of linear trends.
ALFF analysis
We used REST software to calculate ALFF (Zang et al. 2007;
Song et al. 2011). The time series for each voxel was first band-
pass filtered (0.01–0.027 Hz for slow-5 band, and 0.027–
0.073 Hz for slow-4). The filtered time series was fast Fourier
transform (FFT) transformed to obtain power spectrum in the
frequency domain (parameters: taper percent 0, FFT length
shortest). The square root of the power spectrumwas computed
and averaged across pre-defined frequency intervals at each
voxel. This averaged square root was taken as the ALFF at a
particular frequency band. To reduce the effects of participants’
variability, ALFF of each voxel for each participant was further
divided by the global mean ALFF (Zang et al. 2007). The
global mean ALFF value was calculated for each participant
within a group gray matter (GM) mask obtained by selecting a
threshold of 0.2 on the mean GM map of all 51 subjects.
Structural image analysis
The loss of GM in WD may confound the ALFF analysis. To
identify the brain regions with GM loss, we performed a
voxel-based morphometry (VBM) analysis for structural im-
ages (http://www.fil.ion.ucl.ac.uk/spm). Briefly, individual
structural images (3D T1-weighted anatomical images) were
co-registered to the mean functional images after motion cor-
rection using a linear transformation (Collignon et al. 1995).
The transformed structural images were then segmented and
spatially normalized into GM,WM, and cerebrospinal fluid in
the MNI space by using a unified segmentation algorithm
(Ashburner and Friston 2005). Individual GMmaps were fur-
ther modulated to compensate for the effect of spatial normal-
ization using both linear and nonlinear methods. The GM
images underwent a spatial smoothing using 4-mm full width
at half maximum (FWHM) Gaussian kernel. The resultant
images were used to identify the brain regions with GM loss.
Moreover, these maps were also taken into the following sta-
tistical analysis to examine the effects of GM atrophy on the
functional results. In the study, we utilized the mean GMmap
(threshold =0.2) to generate a group-based GMmask and used
this mask for analyzing ALFF differences between the normal
and WD groups.
Table 1 Characteristics of the
participants WD (N = 28) NC (N = 27)
Gender (male/female) 18/10 15/12
Age (years) 16–27 (21.43 ± 3.56) 17–31(23.41 ± 2.65)
Education (years) 8–14 (10.19 ± 1.33) 9–15 (11.02 ± 2.52)
Handedness 28 right-handed 27 right-handed
WD duration (years) 4–9 (6.67 ± 1.46)
WD types neurologic
The KF ring 28 WD with the KF ring
24-h urinary Cu (μmol/day) 1–6 (2.42 ± 1.48)(N = 19)
CP (mg/dL) 3.43–13.02 (6.15 ± 2.51)(N = 19)
WDWilson’s disease, NC Normal controls, N Number, KF Kayser-Fleischer, Cu Copper, CPN Ceruloplasmin
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Statistical analysis
Avoxel-based two-sample t-test was applied on the smoothed
GM intensity maps to determine the results of GM loss in the
WD patients. We performed a two-way repeated-measure
analysis of variance (ANOVA) on a voxel-by-voxel basis with
group (WD patients and normal controls) as a between-subject
factor and frequency band (slow-4 and slow-5) as within-
subject factors in which the GM intensity maps were entered
as covariates. Monte Carlo simulation was utilized to correct
for multiple comparisons by using the Resting-State fMRI
Data Analysis Toolkit (version 1.8) (Song et al. 2011). A
corrected significance level of P = 0.05 was obtained by a
combined threshold of P = 0.01 for each voxel and an extent
threshold of 66 voxels (cluster size >1782 mm3). The correla-
tion analyses were conducted after GM correction.
Spearman’s correlation coefficient was used to study the asso-
ciation between LFO amplitudes and biochemical parameters,
i.e., Cu ( μmol/day) and CP (mg/dL).
Results
GM volume
VBM analysis revealed decreased GM volume in the basal gan-
glia, bilateral cerebellum, right superior and left middle occipital
gyrus, right middle frontal gyrus, bilateral medial frontal gyrus,
left precentral gyrus, left paracentral lobule, and increased GM
volume in bilateral parahippocampal gyrus (Fig. 1, Table 2).
ALFF (slow 5: 0.01–0.027 Hz, slow 4: 0.027–0.073 Hz)
changes in Wilson’s disease
Figures 2 and 3 showed the main effects from the two-way
repeated-measure ANOVA. Brain regions showing a sig-
nificant main effect for frequency band were identified
in the medial frontal gyrus (Fig. 2, slow-5 > slow-4), inferior
temporal gyrus, insula, basal ganglia, hippocampus/
parahippocampal gyrus, and thalamus bilaterally (Fig. 2,
slow-5 < slow-4). Figure 3 shows brain regions with
a main effect of group, including the cerebellum poste-
rior lobe, inferior temporal gyrus, brain stem, basal
ganglia (patient > control), cerebellum anterior lobe
and medial frontal gyrus (patient < control). We ob-
served significant interaction between frequency band
and group in the cerebellum and left middle frontal
gyrus (Fig. 4). Further post-hoc t-test revealed that ALFF
abnormalities were greater in the slow-5 than in the slow-4
band.
Correlation analyses
The associations between LFO amplitudes and biochem-
ical parameters, i.e., Cu and CP were analyzed. The Cu
level was found to be positively correlated with Slow-5
in the left cerebellum (Fig. 5a), but not with Slow-4.
Positive correlations were also found between CP and
ALFF values in the right cerebellum in Slow-5
(Fig. 5b) and in the bilateral cerebellums in Slow-4
(Fig. 5c).
Fig. 1 GM changes in WD patients as compared to normal controls (two-sample t-tests)
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Discussion
In the present study, we examined changes in ALFF in WD
patients at different frequency bands (slow-5: 0.01–0.027 Hz;
slow-4: 0.027–0.073 Hz) with GM correction. We found a
general brain atrophy in WD patients, and widespread differ-
ences in ALFF of the two bands in many brain regions.
Specifically, compared to normal controls, WD patients had
increased ALFF in the posterior lobe of the cerebellum,
inferior temporal gyrus, brain stem, basal ganglia, and
decreased ALFF in the anterior lobe of the cerebellum
and medial frontal gyrus, with greater group difference
in the slow-5 band than in the slow-4 band in the cer-
ebellum and left middle frontal gyrus. Correlation anal-
ysis revealed consistently positive correlations between
Cu, CP and ALFFs in the cerebellum.
Table 2 Brain regions showing
significant GM differences
between patients and controls
Brain regions Voxels MNI coordinates (mm) T value
x y z
WD < NC
Basal ganglia 2281 -18 12 0 -12.39
Left Cerebellum 291 -27 -81 -57 -5.06
Right Cerebellum 277 27 -81 -54 -4.07
Left precentral gyrus 187 -45 -12 36 -4.38
Left paracentral lobule 135 0 -21 54 -4.06
Right middle frontal gyrus 184 51 12 33 -4.21
Right medial frontal gyrus 98 3 36 -15 -3.78
Left medial frontal gyrus 127 -3 42 27 -3.49
Right superior occipital gyrus 176 21 -93 15 -4.53
Left middle occipital gyrus 155 -30 -93 -6 -3.46
WD > NC
Left parahippocampal gyrus 107 -12 -6 -39 5.27
Right parahippocampal gyrus 112 15 -9 -39 5.56
Note: x, y, z, coordinates of primary peak locations in the MNI space; T, statistical value of peak voxel showing
ALFF differences between two groups. P < 0.05, corrected for multiple comparisons
Fig. 2 Frequency-specific ALFF deficits. Hot color represents greater ALFF in the slow-5 band than in the slow-4 band, whereas blue color
represents lower ALFF
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Changes in GM volume
The VBM analysis showed that the decrease of GM volumes
was most significant in the basal ganglia and were also found
in cerebellum, middle and medial frontal gyrus, superior and
middle occipital gyrus, precentral and paracentral lobule. The
results were consistent with previous MRI studies investigat-
ing structural changes in WD patients (Magalhaes et al. 1994;
Starosta-Rubinstein et al. 1987), which showed that most ob-
vious lesions were seen in the basal ganglia, and generalized
brain atrophy was also common. Because the GM atrophy
may lead to artificial reduction in regional ALFF results, all
the functional results in the current study have been adjusted
with GM correction.
Abnormal ALFF activity in WD patients
Compared to normal controls, WD patients had increased
ALFF in the posterior lobe of the cerebellum, inferior tem-
poral gyrus, brain stem, basal ganglia, and decreased ALFF
in the anterior lobe of the cerebellum and medial frontal
gyrus. These results suggest specific spontaneous neural
activity in different brain regions in WD may have differ-
ent characteristics from healthy people’s. These regions
showing abnormal LFO amplitude echoed with the neuro-
logical symptoms of WD disease. Previous observations
have documented neurological symptoms in WD patients
in the form of parkinsonism (cogwheel rigidity, bradykine-
sia or slowed movements and a lack of balance are the
most common parkinsonian features), masked facial ex-
pressions, ataxia (lack of coordination) or dystonia (twist-
ing and repetitive movements of part of the body) (Lorincz
2010). Since lesions of the basal ganglia and cerebellum
will lead to motor deficits in animals and humans (Albin
et al. 1989; Chesselet and Delfs 1996; Jueptner and Weiller
1998; Barinaga 1996), the abnormal ALFFs observed in
basal ganglia and cerebellum are possibly responsible for
the motor control or movement-related impairment in WD
patients. Starosta-Rubinstein et al. evaluated 31 WD pa-
tients with detailed neurologic and medical examinations
and found dystonia and bradykinesia correlated with puta-
men lesions, and dysarthria correlated with both putamen
and caudate lesions (Starosta-Rubinstein et al. 1987). On
the other hand, the abnormalities in the brainstem may result
in changes in sensation, muscle weakness, swallowing and
speech difficulty, and co-ordination problems in WD patients
(Ertekin et al. 2000; Carmichael et al. 1965). Moreover, the
cognition problems (i.e. impulsivity, impaired judgement, pro-
miscuity, apathy and executive dysfunction, slow thinking,
and memory loss etc.) and psychiatric problems (i.e. depres-
sion, anxiety and psychosis etc.) due to WD (Ala et al. 2007;
Lorincz 2010) might result from the joint abnormal functions
of the medial frontal gyrus, inferior temporal gyrus and other
subcortical regions such as basal ganglia (Ridderinkhof et al.
2004; Chan et al. 2001; Kempton et al. 2011).
In addition, our results showed greater ALFF values for
slow-5 band than slow-4 band in the medial frontal gyrus,
and greater ALFF values for slow-4 band than slow-5 band
in the inferior temporal gyrus, insula, basal ganglia,
hippocampus/parahippocampal gyrus, and thalamus,
supporting the results by Zuo et al. (2010) revealing that stron-
ger ALFF at slow-5 tended to be present in the cortical struc-
tures, and slow-4 tended to be in the subcortical structures.
Specifically, we observed that the ALFF abnormalities in the
cerebellum and middle frontal gyrus were greater in the slow-
5 than in the slow-4 band, indicating band-specific abnormal
ALFF in WD patients.
Fig. 3 Regions with ALFF difference between WD and normal groups. Hot color represents higher ALFF in the WD group than in the control group,
whereas blue color represents lower ALFF
Fig. 4 Areas showing greater difference in slow-5 than in
slow-4 between WD and normal groups
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Correlations between LFO amplitudes and biochemical
parameters
To study the associations between LFO amplitudes and bio-
chemical measures could help us better understand the rela-
tionship between ALFF values and diagnosis of WD. The
results show positive correlations between Cu and slow-5,
CP and ALFFs at both frequency bands (slow-4 and slow-5)
in the cerebellum. It has been shown that most copper is de-
posited in the basal ganglia of WD, which normally partici-
pate in the coordination of movement. Damage to these areas,
by Fenton chemistry, produces the neuropsychiatric symp-
toms seen in Wilson’s disease (de Bie et al. 2007). However,
we didn’t find the correlations between Cu, CP and ALFF in
the basal ganglia. This may be because all of our ALFF results
have been adjusted with GM correction andWD patients have
a large GM volume loss in the basal ganglia region as indicat-
ed by the VBM analysis. As a result, the information revealed
by ALFF is limited in the basal ganglia. By contrast, WD
patients showed strong abnormal ALFF activity in large re-
gions of the cerebellum, which area also plays an important
role in motor control. Thus, the correlations found between
ALFF and biochemical measures such as Cu and CP in the
cerebellum indicate the WD related changes in the movement
function.
Future studies could consider taking patients with he-
patic WD as the control, which would be optimal to com-
pare the brain activity changes in the neurological WD.
Moreover, it would be interesting to investigate ALFF
changes before and after the treatment, and to correlate
the ALFF changes with the clinical outcome. All of our
WD patients were treated with DMPS, which is widely
used in China for more than 30 years (Chen et al. 2016;
Yang and Cheng 2002; Wang et al. 2003). We noted that
clinical practice with WD patient in Europe and the
United States used Penicillamine instead of DMPS
(European Association For The Study Of The Liver
2012). Although the general mechanisms underlying
DMPS and Penicillamine might be similar (Gerhardsson
and Aaseth 2016), whether our findings with ALFF ab-
normalities were universal characteristics of WD patient
required further investigation.
Conclusion
This study shows that WD patients had abnormal LFO ampli-
tude in many brain regions, including the cerebellum, inferior
temporal gyrus, brain stem, basal ganglia, and medial frontal
gyrus, with different spatial patterns in different frequency
bands, and there was a correlation between LFO amplitudes
and biochemical measures in the cerebellum. Thus, the accu-
mulation of copper profoundly impaired intrinsic brain activ-
ity and the impairments seem to be frequency-dependent.
These results provide further insights into the understanding
of the pathophysiology of WD.
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